Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis.

@article{Joode2014PerformanceOT,
  title={Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis.},
  author={A. D. de Joode and C. Roozendaal and M. J. van der Leij and L. Bungener and J. Sanders and C. Stegeman},
  journal={European journal of internal medicine},
  year={2014},
  volume={25 2},
  pages={
          182-6
        }
}
BACKGROUND In anti-neutrophil cytoplasmic antibodies (ANCA) associated small vessel vasculitis (AAV), rapid testing for ANCA and anti-glomerular basement membrane (GBM) antibodies may be beneficial for therapeutic purpose. OBJECTIVE We analysed the diagnostic performance of two rapid ANCA and anti-GBM test methods in 260 patients with suspected AAV. METHODS Between January 2004 and November 2010, we analysed 260 samples by qualitative Dotblot (Biomedical Diagnostics); retrospective analysis… Expand
Evaluation of the diagnostic performance of an immunoblot for ANCA and anti-GBM antibody detection
TLDR
The immunoblot is a useful addition to current guidelines, particularly when a rapid diagnosis is necessary, and has advantages over other assays in terms of time, costs, and interpretation of results. Expand
An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice
TLDR
Differences within countries and between countries in the use of ANCA indirect immunofluorescence in the algorithm, application of distinct methods for MPO- and PR3-ANCA, the daily availability of new ANCA results, and interpretation of test results are revealed. Expand
Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitis.
TLDR
New developments in the methodology of testing, the pitfalls in using these tests as diagnostic tools, and the value of serial ANCA testing for the follow-up of patients with ANCA-associated vasculitis including treatment decisions are discussed. Expand
The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis.
TLDR
Findings support the 2017 international consensus that primary anti-PR3 and anti-MPO screening by immunoassay, based on superior immunoASSay sensitivity without the need for IIF ANCA testing, improves the diagnostic workup of AAV. Expand
The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis
TLDR
This review highlights the contributory roles played by various factors (e.g. genetics, environment, B and T-regulatory cells, toll-like receptors, etc.) in the pathogenesis of AAV and demonstrates evidence on novel serum biomarkers that have been shown to correlate with disease activity in AAV. Expand
Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness
TLDR
The novelties in ANCA diagnostics are summarized and the possible implications of these developments for the different ANCA algorithms that are currently applied in routine diagnostic laboratories are discussed. Expand
associated vasculitis – new insight into pathogenesis , diagnostics and therapy * *
ANCA (anti-neutrophil cytoplasmic antibodies) associated vasculitis is common kind of vasculitis. Frequency of this vasculitis increases last years. Both genetic and environmental factors areExpand
Anti-neutrophil cytoplasmic antibodies and their clinical significance
TLDR
The techniques for ANCA detection, ANCA staining patterns and their clinical significances are reviewed. Expand
Falsely positive anti-glomerular basement membrane antibodies in a patient with hantavirus induced acute kidney injury - a case report
TLDR
Hantavirus infection may induce anti-GBM antibodies, falsely suggestive of anti- GBM glomerulonephritis when diagnosing acute renal failure, which may lead to diagnostic dilemmas with crucial therapeutic consequences. Expand
Laboratory testing for systemic autoimmune diseases
TLDR
Novel bedside test procedures for these antibodies allow an early diagnosis in critically ill patients, and new biomarkers for polymyalgia rheumatic and for spondyloarthritides are described, but their clinical relevance remains uncertain and necessitates further studies. Expand
...
1
2
...

References

SHOWING 1-10 OF 25 REFERENCES
ANCA-GBM Dot-Blot: Evaluation of an Assay in the Differential Diagnosis of Patients Presenting with Rapidly Progressive Glomerulonephritis
TLDR
The ANCA-GBM dot-blot diagnostic test is a useful screening tool in situations where conventional ANCA testing is not readily available with excellent performance for PR3-ANCA detection, but less optimal sensitivity for MPO-AN CA and specificity for anti- GBM detection. Expand
Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
TLDR
In patients with both anti- GBM antibodies and MPO-ANCAs, histological findings differ from those of patients with anti-GBM antibodies only, however, renal survival in these patients is not better than that in anti-TBM-positive patients and is worse compared with patients with MPO -ANCAs only. Expand
Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
Rises in antineutrophil cytoplasmic antibodies (ANCA) directed against proteinase 3 (PR3) have predictive potential for a relapse of Wegener's granulomatosis (WG). To assess the value of imageExpand
Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
TLDR
A testing strategy based on screening for ANCA with ELISA or FEIA (without prior IIF) is a valuable alternative to screening with IIF and confirming withELISA orFEIA. Expand
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)
TLDR
Any report of positive neutrophil fluorescence issued before the ELISA results are available should indicate that positive fluorescence alone is not specific for the diagnosis of Wegener granulomatosis or microscopic polyangiitis and that decisions about treatment should not be based solely on the ANCA results. Expand
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
TLDR
The value of the IIF test for ANCA detection can be greatly increased by the addition of a well standardized antigen-specific ELISA, and the diagnostic specificity increased to 99%. Expand
Antineutrophil cytoplasmic antibodies (ANCA)
TLDR
ANA levels are useful to monitor disease activity but should not be used by themselves to guide treatment, and a significant increase in ANCA titres, or the reappearance of ANCA, should alert the clinicians and lead to a stricter patient control. Expand
Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3
TLDR
Conventional ELISAs using proteinase 3 (PR3) immobilised to the surface of the ELISA plate show great variations in performance and often lack sensitivity, so hsPR3-ANCA ELISA immobilises PR3 to improve sensitivity. Expand
Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA?
TLDR
The international consensus statement on ANCA should be revised because it became clear that antigen‐specific tests, in which antigens are directly coated to the solid phase, demonstrate highly variable sensitivities and specificities, whereas when capture or anchor technologies are used, more reproducible results are obtained. Expand
Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.
TLDR
Both direct and capture ELISA assays using either native or recombinant MPO are sensitive techniques to detect MPO-ANCA in patients with pauci-immune NCGN. Expand
...
1
2
3
...